AcelRx Pharmaceuticals Picks Vincent Angotti for CEO Post

Xconomy San Francisco — 

Vincent Angotti is joining AcelRx Pharmaceuticals (NASDAQ: ACRX) as the Redwood City, CA-based pain drug developer’s CEO. Agnotti was most recently CEO of XenoPort. His experience also includes roles at Reliant Pharmaceuticals and Novartis (NYSE: NVS). Angotti will start at AcelRx on March 6.